Category
Tadalafil
CAS Number
171596-29-5
Molecular Formula
C₂₂H₁₉N₃O₄
Molecular Weight
389.40 g/mol
Synonym

(6R,12aR)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methylpyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione ; (2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione ; (6R,12aR)-6-(benzo[d][1,3]dioxol-5-yl)-2-methyl-2,3,12,12a-tetrahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione ; (6R,12aR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)pyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione; Pentadafil ; Tadalafil ; Talmanco ; Tardenafil ; Tildenafil ;UK 336017 ; Zydalis;1,6]pyrido[3,4-b]indole-1,4-dione;Cialis; GF 196960; IC 351; ICOS 351; Tildenafil; UK 336017; Pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione, 6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12ahexahydro-2-methyl-, (6R-12aR)-; (6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-[3,4-(methylenedioxy)phenyl]pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione (USP)

Keywords
Enzyme inhibitors
Pharmaceutical Standards
Intermediates
Fine Chemicals
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Tadalafil standard refers to the established quality, purity, and dosage specifications used to ensure the drug’s safety and effectiveness in treating Erectile Dysfunction and Benign Prostatic Hyperplasia; it includes parameters such as identity, strength, dissolution rate, and impurity limits, which are defined by official pharmacopeias like the United States Pharmacopeia to maintain consistent pharmaceutical quality.